O

Ossur hf
OTC:OSSUY

Watchlist Manager
Ossur hf
OTC:OSSUY
Watchlist
Price: 5 USD Market Closed
Market Cap: $2.2B

Net Margin

7.1%
Current
Improving
by 0.4%
vs 3-y average of 6.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.1%
=
Net Income
$56.9m
/
Revenue
$804.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
7.1%
=
Net Income
$56.9m
/
Revenue
$804.3m

Peer Comparison

Country Company Market Cap Net
Margin
IS
Ossur hf
CSE:OSSR
11.3B DKK
Loading...
US
Abbott Laboratories
NYSE:ABT
192B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
131.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
112.1B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
46B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
45.4B USD
Loading...
US
Resmed Inc
NYSE:RMD
39.5B USD
Loading...

Market Distribution

Higher than 70% of companies in Iceland
Percentile
70th
Based on 35 companies
70th percentile
7.1%
Low
-297.4% — 0%
Typical Range
0% — 7%
High
7% — 75.1%
Distribution Statistics
Iceland
Min -297.4%
30th Percentile 0%
Median 1.3%
70th Percentile 7%
Max 75.1%

Ossur hf
Glance View

Market Cap
2.2B USD
Industry
Health Care

Össur hf. is an Icelandic company that stands as a quiet marvel in the realm of orthopedic innovation, specializing in the development of non-invasive equipment designed to enhance human mobility. Born out of a small prosthetics shop in Reykjavik in 1971, the company has grown into a global leader in orthopedic solutions. At its core, Össur's operations revolve around the invention and commercialization of cutting-edge prosthetics, braces, and supports aimed at improving the quality of life for people who face limb challenges due to injuries, disabilities, or age-related conditions. The company's ethos of "Life Without Limitations" guides its pursuit to blend medical technology and engineering in a way that restores human dignity and functionality, manifesting a unique synergy between advanced robotics and biology. Commercially, Össur thrives by leveraging its commitment to research and development, channeling substantial investment into creating high-demand products characterized by reliability, adaptability, and innovation. Revenue streams primarily flow from the sale of prosthetic limbs and associated components, together with orthopedic support products that are distributed both directly and through a network of wholesalers and medical professionals worldwide. By maintaining a diversified product line and focusing on customer-centric customization, Össur meets a significant demand within healthcare systems, insurance providers, and direct consumer markets. The company's ability to translate its scientific prowess into marketable and life-enhancing solutions has cemented its reputation as a key player in the med-tech industry, aligning financial success with a meaningful social mission.

OSSUY Intrinsic Value
Not Available
O
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
7.1%
=
Net Income
$56.9m
/
Revenue
$804.3m
What is Ossur hf's current Net Margin?

The current Net Margin for Ossur hf is 7.1%, which is above its 3-year median of 6.7%.

How has Net Margin changed over time?

Over the last 3 years, Ossur hf’s Net Margin has increased from 1.7% to 7.1%. During this period, it reached a low of 1.7% on Mar 3, 2021 and a high of 8.9% on Dec 31, 2021.

Back to Top